AzTrials
AzTrials

Femoroacetabular Impingement SyndromeNCT07472400

Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months After Hip Arthroscopy for Femoroacetabular Impingement Syndrome

An observational study of Femoroacetabular Impingement Syndrome and Healthy Participants, run by University of Liege at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study is to identify the factors associated with successful rehabilitation following hip arthroscopy for femoroacetabular impingement syndrome and to highlight any persistent functional deficits at different key stages of rehabilitation. This is a controlled multi-observational study. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
How many people
60 participants
Where
1 siteBelgium
Study dates
1 Mar 2026to 30 Jun 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Adults aged 18-40 years will be recruited. The patient group will include individuals diagnosed with femoroacetabular impingement syndrome who are scheduled to undergo hip arthroscopy by specialized surgeons. A healthy control group without a history of hip pathology will be recruited from the local community matched as closely as possible to the patient group for demographic parameters.

Who may be able to join

  • Subjects with femoroacetabular impingement syndrome, with corresponding clinical symptoms and signs, as well as validation by imaging
  • Subjects who have already consulted a surgeon specializing in hip arthroscopic surgery and whose surgery is planned to treat femoroacetabular impingement syndrome
  • Subjects aged between 18 and 40

Who cannot join

  • History of rheumatic disease, dysplasia or pediatric disease affecting the hip (Legg-Calvé; superior femoral epiphysiolysis)
  • Subject who has already undergone surgery on the hip joint
  • Subjects with a history of injury to the muscles involved in the assessments within the last year

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Raphaël Leroy, PT, PhD candidate contact

+32491128430

rleroy@uliege.be

Belgium1 site, 1 recruiting
  • Blanc Gravier sports centers

    Sart Tilman, Liège, 4000

    Raphaël Leroy, PT, PhD candidate, +32491128430, rleroy@uliege.be

    Recruiting

Other trials in Belgium

About this study

Official title: Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months

The aim of this study is to identify the factors associated with successful rehabilitation following hip arthroscopy for femoroacetabular impingement syndrome and to highlight any persistent functional deficits at different key stages of rehabilitation. This is a controlled multi-observational study. The pathological hip of patients will be compared to their second healthy hip as well as to a healthy control group.

Assessments of mobility, strength, functional tests, and questionnaire submissions will take place before the intervention and 3 and 6 months after the intervention.

Keywords
Femoroacetabular impingement syndrome, Physical impairments, Questionnaires, Strength, mobility
Medical subject headings
Femoracetabular Impingement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07472400
Study groupRoleWhat they receive
Patient groups: 30 subjects with femoroacetabular impingement syndromeNot described
Control group : 30 subjects with healthy hipsNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle strength in Nm

    Muscular strength is measured using a fixed dynamometer

    Measured: Pre-intervention, at 3 months and 6 months post-intervention

  2. Hip mobility in degree

    Hip mobility is measured using an electronic goniometer

    Measured: Pre-intervention, at 3 months and 6 months post-intervention

  3. Functional results on the Y Balance Test

    The functional results of the Y balance test will be measured using the composite score.

    Measured: Pre-intervention, at 3 months and 6 months post-intervention

  4. Functional results in the single-leg squat test

    The functional results of the single-leg squat test will be measured using the SIngle-leg squat Movement Performance scaLe for Individuals with FemoroAcetabular Impingement syndrome (SIMPLAI-FAI). The score on this scale ranges from 0 to 8. A higher score indicates a better functional outcome.

    Measured: Pre-intervention, at 3 months and 6 months post-intervention

  5. Measurements of patient-reported outcomes using the Hip-Return to Sport After Injury Scale (HIP-RSI)

    Analysis of scores obtained on the HIP-RSI questionnaire. This questionnaire assesses psychological readiness to resume sports activities following hip surgery. It consists of six items, and the final score ranges from 0 to 100. A higher score indicates greater psychological readiness to return to sports activities.

    Measured: Pre-intervention, at 3 months and 6 months post-intervention

  6. Measurements of patient-reported outcomes using the International Hip Outcome Tool-12 (iHot-12) questionnaire

    Analysis of scores obtained on the iHot-12 questionnaire. This questionnaire assesses the quality of life of young, active patients suffering from hip problems. It consists of 12 items and the final score ranges from 0 to 100. A score of 100 indicates full function and no symptoms, whereas a score of zero signifies maximum limitations and extreme symptoms.

    Measured: Pre-intervention, at 3 months and 6 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2026
  2. Study start1 Mar 2026
  3. Primary completion30 Jun 2027 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07472400
Sponsor's protocol ID
2026-063
Status last verified
Apr 2026
First submitted
5 Mar 2026
Last updated
5 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The principal investigator behind the study project will be the only person to process the data collected during this study. There are no plans to share this data.

Questions about this trial

What is this clinical trial studying?

An observational study of Femoroacetabular Impingement Syndrome and Healthy Participants, run by University of Liege at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Raphaël Leroy, PT, PhD candidate (+32491128430, rleroy@uliege.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle strength in Nm (time frame: Pre-intervention, at 3 months and 6 months post-intervention). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in